International Journal of Community Medicine and Public Health

Soumya C et al. Int J Community Med Public Health. 2020 Apr;7(4):1318-1323

http://www.ijcmph.com

pISSN 2394-6032 | eISSN 2394-6040

Primary care-based prevalence of cutaneous lesions among type 2 diabetes mellitus in urban areas of Belagavi, India

Chippagiri Soumya1*, Sanjay Kambar2, Shivkumar Patil3


1Department of Community Health, St. John’s Medical College, Bangalore, Karnataka, India

2Department of Community Medicine, Jawaharlal Nehru Medical College, K.L.E. Academy of Higher Education and Research, Belagavi, Karnataka, India

3Department of Dermatology, Jawaharlal Nehru Medical College, K.L.E. Academy of Higher Education and Research, Belagavi, Karnataka, India

Received: 23 January 2020

Revised: 28 February 2020

Accepted: 03 March 2020

*Correspondence:

Dr. Chippagiri Soumya,

E-mail: soumya.chippagiri87@gmail.com

Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Background: Diabetic complications affects every organ and skin is no exception. Cutaneous signs are extremely valuable to physicians as some alert the diagnosis of diabetes mellitus and reflect on glycemic control and lipid metabolism. To estimate the prevalence of cutaneous lesions in urban areas of Belagavi and to find the associated factors.

Methods: Data was collected from type 2 diabetes mellitus patients attending Primary care Urban Health Centre. Current diabetics from the Diabetic Register, maintained in the Urban Health Centres were included, and patients’ medical records were reviewed for information regarding duration, medications and complications of diabetes. Information about socio-demographic profile, general physical examination, systemic and cutaneous examination were recorded using validated, predesigned and pretested proforma. All patients were asked detailed history regarding skin complaints, duration of type 2 diabetes mellitus, family history and treatment of diabetes mellitus. All cases underwent cutaneous examination under natural light. Cases where diagnosis was doubtful were confirmed by the Department of Dermatology at K.L.E.’s Dr. Prabhakar Kore Hospital & Medical Research Centre.

Results: Of 180 study participants, average age was 59.88±11.06 years and 74.44% were females. 2.56±0.99 years was the mean duration of diabetes and 89.44% were on oral hypoglycemic agents. Prevalence of cutaneous manifestations was found to 48.88%. The cutaneous lesions were asymptomatic in majority of the participants (48.86%) and progressive 48 (54.5%).

Conclusions: Cutaneous manifestation were highly prevalent and requires for the physician to be vigilant.

Keywords: Cutaneous lesions, Diabetes mellitus, Prevalence study, Urban, India

INTRODUCTION

Diabetes mellitus is a worldwide problem being the most common metabolic disorder. At present there are more than 422 million diabetics globally and predicted to double in 2030 with a maximum increase in India afflicting up to 79.4 million individuals.1,2

These sheer numbers indicate the need for in-depth understanding of every aspect of diabetes. This endocrine disorder affects every part of the body with micro and macrovascular involvement and skin is no exception. There is a paucity in availability of enough evidence to explain the pathophysiology of a diabetic skin. Some diabetes associated skin conditions are said be a direct result of hyperglycemia and some state diabetic complications such as vasculopathy and neuropathy impair cutaneous homeostasis leading to altered mechanical and functional properties of skin.3 Non - enzymatic glycosylation occurs normally with aging but the process is greatly accelerated in diabetes.4 The fact that the skin can independently act as a storehouse for sugar, physiologic and pathologic studies of the skin give a far better insight than by studies of the blood alone.5 So hyperglycaemia can be identified earlier than hyperglycemia.

Need for the study

While all other devastating complications of diabetes have been extensively studied, the aspect of dermatological complications is relatively unexplored. Its prevalence is increasing in the present scenario with attention drawn to the aesthetic purpose of skin. This warrants the need to know the burden of cutaneous lesions among type 2 diabetics.

The objective of the study was to estimate the prevalence of cutaneous lesions in type 2 diabetes mellitus in urban areas of Belagavi and to find the factors associated with it.

METHODS

This prevalence study is a part of a year-long longitudinal study which looked for cutaneous manifestations in type 2 diabetes mellitus and a part of it is published as a conference abstract in International Journal of Diabetes in Developing Countries. It was conducted in the Primary Urban Health Centre Ashok Nagar and Ram Nagar under field practice area of Department of Community Medicine, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India. Data was collected from January, 2016 to December, 2016 by simple random technique from type 2 diabetes mellitus patients attending the primary urban health centre. Informed written consent was taken. The diagnosis of type 2 diabetes mellitus was confirmed by verifying the Diabetic Register, maintained in the health centers and patients’ medical records were reviewed for information of duration, medications and complications of diabetes.

Patients with clinically diagnosed dermatological condition prior to diagnosis of type 2 diabetes mellitus and immunocompromised patients with skin lesions were excluded. Information about socio-demographic profile, general physical examination, systemic and cutaneous examination were recorded using validated, predesigned and pretested proforma after piloting. All patients were subjected to detailed history regarding skin complaints, duration of type 2 diabetes mellitus, family history and treatment of diabetes mellitus.

All cases were subjected to thorough head to toe cutaneous examination under natural light. They were screened for cutaneous diseases with known or postulated or without a clear pathogenesis as well as those associated with complications and treatment of type 2 diabetes mellitus. Cases with doubtful diagnosis were confirmed by the Department of Dermatology at K.L.E.’s Dr. Prabhakar Kore Hospital and Medical Research Centre.

The study was approved by the Institutional Ethics Committee for Human Subjects’ Research, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research, Belagavi. Data was analysed using Statistical Package for Social Sciences (SPSS), version 21.0 Prevalence of cutaneous lesions and risk factors are presented as percentages. Pearson’s Chi-Square test was used to find out the association between cutaneous manifestations and risk factors. Probability value (p value) of less than 0.05 was considered as significant.

RESULTS

A total of 180 study participants were included. (134) 74.5% were female and 59.88 ±11.06 years was the mean age of participants. 36.3% were illiterate. Mostly participants (83.3%) were unemployed. According to modified B.G. Prasad’s classification, 22 (12.2%) were of class I, 49 (27.2%) were of class II, majority were of class III with 56 (31.1%) participants. 43 (23.8%) were of class IV and 10 (5.5%) were of class V. (Table1).

The study participants’ duration of diabetes varied. (84) 46.7% had diabetes from 1-5 years, (46) 25.5% were living with diabetes for more than 10 years. (Table 1) Most of the study participants, (161) 89.4% were on oral hypoglycemic agents (OHA) that were provided by the urban health centre (Table 2).

Among the 180 study participants the prevalence of cutaneous manifestations was found to be 48.8% (Figure 1). The onset of lesion was insidious in more than half of the participants (67.0%) and 54.5% experienced progression of the lesion (Table 3).

The cutaneous lesions were asymptomatic in majority of the participants (43) 48.86%. The other symptoms included were itching (27.2%), burning sensation (22.7%), pain (20.4%), discharge (6.8%). (68) 77.2% of them had single associated symptom, (17) 19.3% had two associate symptoms and (3) 3.4% had three symptoms associated with the skin lesions (Figure 2).

Figure 1: prevalence of cutaneous manifestations in type 2 diabetes. | Present 49% Absent 51%
Figure 1: prevalence of cutaneous manifestations in type 2 diabetes.
Table 1: Sociodemographic distribution of study participants.
Table reproduced from source PDF page 3
Table 2: Morbidity profile of study participants.
Table reproduced from source PDF page 3
Table 3: Distribution showing nature of the lesions.
Table reproduced from source PDF page 3
Figure 2: Distribution of associated symptoms of cutaneous manifestation. | 27.20% 22.70% 20.40% 6.80% 48.80% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00%
Figure 2: Distribution of associated symptoms of cutaneous manifestation.
Table 4: Association of risk factors to cutaneous lesions.
Table reproduced from source PDF page 4

DISCUSSION

The present study was a part of a year-long longitudinal study conducted in the primary care setting of Urban Health Centers which are the field practice areas of Department of Community Medicine, Jawaharlal Nehru Medical College, K.L.E. University, Belagavi.

Many of the cutaneous lesions are either associated with diabetes or are a sequalae. In this study the prevalence of cutaneous manifestations was found to be in 48.88%. However, the overall prevalence of cutaneous manifestations varied from 11.4 to 91.2%.6,7 Such a range of prevalence could be noted because the mere absence of a uniform attention paid to the importance of skin and its examination. Many of the associations even considered to be accidental due to high prevalence of diabetes in the general population.8

An association between cutaneous manifestations and age was statistically significant. The presence of lesion increased with age.

With no manifestations in the youngest age group and maximum number of manifestations in the age group of 55-65 years with 44 (66.7%) lesions. Then the lesions decreased with 6 (37.5%) diabetics with lesion in 75-85 years age group. This decrease was seen as the number participants in this age group were fewer as well. Ageing affects the skin through both internal and external processes leading to progressive loss of skin integrity.9 Most people over 65 years have at least one skin disorder and many have two or more.10

71 (53.0%) female study participants showed greater presence of cutaneous lesions. This was noticed as the female participants were more in number. Also, the women were noticed to have prolonged soaking of feet in water during household activities such as washing clothes and utensils which increased the occurrence of Tinea Paedis. Estrogen is hypothesized to be critical for maintenance of skin integrity by stimulating DNA repair. Skin aging can be significantly delayed by the administration of estrogen at menopause and has been demonstrated to be at least partially reversible with Estrogen Replacement Therapy.9 But, estrogen excess is known to cause Acanthosis nigricans and deficiency causes xerosis and atrophy.4

Most of the skin lesions were found among those who were illiterate, (53.8%), most of them were unemployed (48.0%) and belonged to the lower socioeconomic group (81.4%). Similar finding was noted in a study conducted in a diabetic Clinic in UAE, with 51% Illiterate patients and they were less likely to practice foot care Illiteracy and diabetic foot complications.11 Illiteracy is a barrier to health seeking making such patients more vulnerable to out of pocket expenditure or worse ignorance to preventable and treatable lesions. This reflects on the general perception of skin playing the utmost importance from cosmetologically point of view rather than the reflector of internal milieu. The most expensive complication of diabetes affecting the foot can be prevented effectively with homebased foot care.

In this study the presence of cutaneous manifestations was most commonly observed when the duration of diabetes was for 1 to 5 years with 46 (54.8%) of study participants with lesions. Also, the absence of lesion was pronounced in those with duration of diabetes less than 1 year with 12 (60.0%) among those without manifestations. Hence the longer the duration of type 2 diabetes mellitus more the skin lesion. This reflects on poor early detection of the diabetic status and high lights a multi-dimensional lacuna, from implementational of the national program to individual involvement in their health care of the non-communicable disease. In the study conducted by Nandini Chatterjee et al., duration of diabetes was 1-10 years in 290 patients and 201 had more than 10 years of diabetes.12 Vahora et al, studied 300 diabetics, 62.33% had the duration of diabetes was less than 6 years and 83.7% of the patients the duration was less than 10 years.13 In a study conducted by Ragunaha et al, the mean duration of diabetes was 5.5±5.8 years and 82 % of patients the duration was less 10 years.14 Further cohort studies are recommended which help study the duration for development of skin lesions.

The study showed most of the lesions were present in those on insulin (54.5%). The number of lesions noted among those on oral hypoglycemic agents were 49.1% and no lesions among those who were on ayurvedic medication. Most of the study participants, (161) 89.44% were on oral hypoglycemic agents. Manish N. Kadam et al. showed that 10% patients were only on insulin therapy, the other 76% patients were on hypoglycemic drugs and 14% patients were on were on no treatment.15 Ghulam Hussain Baloch et al. had 70 type diabetics on oral drugs and 2 on insulin out of the 90 patients studied.16 Another study conducted by Ahmed et al, 82.2% were on oral hypoglycemic agents, 12.9% were on insulin and 4.9% were on combination therapy.17 This finding gives a perspective of the possible complications associated allopathic medications. However, the severity with the mode of treatment is not known. An RCT to probe into other traditional methods for management of chronic diseases like diabetes is recommended.

It is worrisome to note the onset of lesion was insidious in 64.77% and progressive in 55.68%. The cutaneous lesions were asymptomatic in majority of the participants (48.86%). There was a statistical significance of occurrence of cutaneous manifestations and the socioeconomic status of the individual. The economic burden is a possibility for the lesions to be progressive in nation. While neuropathy is known pathology for asymptomatic diabetic lesions, lack of awareness of diabetic foot care is the biggest attributer for it being the most expensive complication of diabetes.18

The limitation of this study was the confounding factors of obesity and seasonal variations were not eliminated. Measuring the glycemic status (HbA1c) was beyond the scope of this study.

CONCLUSION

Cutaneous manifestations were highly prevalent causing considerable morbidity especially in the elderly and those of lower socioeconomic data. Owing to increased susceptibility of diabetic skin to infections emphasis should be on self-care practices to overcome fatal outcomes. However, there are cutaneous markers such as Acanthosis nigricans and skin tag which are considered precursors for the development of diabetes mellitus which the treating physician should also be vigilant in detection and management in early stage lesions.

ACKNOWLEDGEMENTS

Staff of Urban Health Centre, Ashoknagar and Ramnagar for the constant help during data collection and all the study participants, whose support made this study possible.

Funding: This study was partially funded and supported by research grant from Research Society for the Study of Diabetes in India (RSSDI)

Conflict of interest: None declared

Ethical approval: The study was approved by the Institutional Ethics Committee

REFERENCES

  1. 1. Global Report on Diabetes; World Health Organization, 2016.
  2. 2. Seema Abhijeet Kaveeshwar, Jon Cornwall. The current state of diabetes mellitus in India; Australasian Med J. 2014;7(1):45-8.
  3. 3. H Seirafi, K Farsinejad, A Firooz, SM Davoudi, RM Robati, MS Hoseini, AH Ehsani, B Sadr. Biophysical characteristics of skin in diabetes: a controlled study. J European Acad Dermatol Venereol. 2009;23(2):146-9.
  4. 4. Fitzpatcrik's Dermatology in General Medicine. 7th Edition. 461-1470.
  5. 5. Erich Urbach. Skin diabetes: hyperglycodermia without hyperglycemia, J Am Med Assoc. 1945;129(6) 438-440.
  6. 6. M. Greenwood. A study of the skin in five hundred cases of diabetes; J Am Med Assoc. 1927;89(10):774-6.
  7. 7. Shahzad M, Robaee AA, Al Shobaili HA, Alzolibani AA, Abdullah A, Al Marshood, Al Moteri B. Skin Manifestations in Diabetic Patients Attending a Diabetic Clinic in the Qassim Region, Saudi Arabia; Med Principles Pract. 2011;20:137-41.
  8. 8. Zamaz Wahid, Anjum Kanjee. Cutaneous Manifestations of Diabetes Mellitus. J Pakistan Med Assoc. 1998;48(304):304-5.
  9. 9. Miranda A. Farage, Kenneth W. Miller, Peter Elsner, Howard I. Maibach. Characteristics of the Aging Skin. Adv Wound Care. 2013;2(1):5-10.
  10. 10. Kligman AM and Koblenzer C: Demographics and psychological implications for the aging population. Dermatologic Clin. 1997;15(4):549-53.
  11. 11. Juma M. Al-Kaabi, Fatma Al Maskari, Paul Craggc, Bachar Afandi, Abdul-Kader Souidd. Illiteracy and diabetic foot complications. Primary Care Diabetes. 2015;470.
  12. 12. Chatterjee N, Chattopadhyay C, Sengupta N, Das C, Sarma N, Pal SK. An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care Hospital of Eastern India. Indian J Endocrinol Metabolism. 2014;18(2):217-20.
  13. 13. Vahora R, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat. Indian J Endocrinology Metabolism. 2013;17(4):659-64.
  14. 14. Ragunatha S, Anitha B, Inamadar AC, Palit A, Devarmani SS. Cutaneous disorders in 500 diabetic patients attending diabetic clinic. Indian J Dermatol. 2011;56(2):160-4.
  15. 15. Kadam MN, Soni PN, Phatale S, Siddramappa B. A study of cutaneous manifestations associated with diabetes mellitus. International J Adv in Med. 2016;3(2):296-303.
  16. 16. Baloch GH, Memon NM, Devrajani BR, Pervez Iqbal P, Thebo NK. Cutaneous manifestations of Type 2 Diabetes Mellitus. J Liaquat University Med Health Sci. 2008;7(2):67-70.
  17. 17. Ahmed K, Muhammad Z, Qayum I, J AyubJ. Prevalence of cutaneous manifestations of Diabetes mellitus. J Ayub Med College Abbottabad. 2009;21(2):76-9.
  18. 18. Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always, Therapeutic Adv Endocrinol Metabolism. 2016;9(1):29-31.